Evidence map›Paper›PMID 36454131›Full record

ArticleAIDS education and prevention : official publication of the International Society for AIDS Education2022

Adapting a Group-Level PrEP Promotion Intervention Trial for Transgender Latinas During the COVID-19 Pandemic.

Scott D Rhodes, Amanda E Tanner, Lilli Mann-Jackson, Jorge Alonzo, Lucero Refugio Aviles, Carla A Galindo, Patricia A Bessler, Cari Courtenay-Quirk, Benjamin D Smart, Manuel Garcia and 3 more

Open access · greenAbstract read
In one paragraph

Article in AIDS education and prevention : official publication of the International Society for AIDS Education, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Integrating CBPR and Implementation Science to Develop a PrEP-Promotion Intervention for Black Transgender Women.Health education & behavior : the official publication of the Society for Public Health Education · 2026
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Scott D RhodesWake Forest University School of Medicine, Winston-Salem, North Carolina.
Amanda E TannerUniversity of North Carolina Greensboro, Greensboro, North Carolina.
Lilli Mann-JacksonWake Forest University School of Medicine, Winston-Salem, North Carolina.
Jorge AlonzoWake Forest University School of Medicine, Winston-Salem, North Carolina.
Lucero Refugio AvilesUniversity of North Carolina Greensboro, Greensboro, North Carolina.
Carla A GalindoCenters for Disease Control and Prevention, Atlanta, Georgia.
Patricia A BesslerCenters for Disease Control and Prevention, Atlanta, Georgia.
Cari Courtenay-QuirkCenters for Disease Control and Prevention, Atlanta, Georgia.
Benjamin D SmartWake Forest University School of Medicine, Winston-Salem, North Carolina.
Manuel GarciaWake Forest University School of Medicine, Winston-Salem, North Carolina.
Tamar GoldenbergUniversity of North Carolina Greensboro, Greensboro, North Carolina.
Ana D SucalditoWake Forest University School of Medicine, Winston-Salem, North Carolina.
Beth A ReboussinDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Wake Forest University · USCenters for Disease Control and Prevention · USUniversity of North Carolina at Greensboro · US

Funding

Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
ACL HHS U01PS005137NCHHSTP CDC HHS U01 PS005137NICHD NIH HHS P2C HD050924
6 · The paper itself

Abstract

The COVID-19 pandemic has profoundly affected the conduct of community-based and community-engaged research. Prior to the pandemic, our community-based participatory research partnership was testing ChiCAS, an in-person, group-level behavioral intervention designed to promote uptake of pre-exposure prophylaxis (PrEP), condom use, and medically supervised gender-affirming hormone therapy among Spanish-speaking transgender Latinas. However, the pandemic required adaptations to ensure the safe conduct of the ChiCAS intervention trial. In this article, we describe adaptations to the trial within five domains. Transgender women are disproportionately affected by HIV, and it is essential to find ways to continue research designed to support their health within the context of the COVID-19 pandemic and future infectious disease outbreaks, epidemics, and pandemics. These adaptations offer guidance for ongoing and future community-based and community-engaged research during the COVID-19 pandemic and/or potential subsequent outbreaks (e.g., monkeypox), epidemics, and pandemics, particularly within under-served marginalized and minoritized communities.

Indexed as

COVID-19HIV InfectionsTransgender PersonsFemaleHispanic or LatinoHumansMalePandemicsCOVIDinterventionLatinaPrEPtransgender

Identifiers

PMID36454131
PMCPMC10552717
OpenAlexW4310710754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.